“Optimal” Dose Finding Could Result In More Late-Stage Drug Success

A paradigm shift from maximum-tolerated dose to effective dose would result in more successful late-stage drug development, FDA Office of Clinical Pharmacology & Biopharmaceutics Pharmacometrics Team Leader Joga Gobburu, PhD, said April 23

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet